Postoperative Bladder Filling After Outpatient Laparoscopic Hysterectomy and Time to Discharge
Part of paid clinical trials in Memphis, Tennessee.
- Sponsor
- University of Tennessee
- Study ID
- NCT06737393
- Status
- Recruiting
Conditions
- Patient Discharge
- Urinary Complication
Eligibility Criteria
- Sex
- FEMALE
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Accepted
Interventions
- Backfill — PROCEDUREParticipants undergoing laparoscopic hysterectomy have the bladder filled with 200 mL saline prior to Foley removal at the end of surgery.
Study Details
The investigators hypothesize that backfilling the bladder postoperatively will reduce time to spontaneous void and subsequent discharge from the post-anesthesia care unit.
Key Dates
- Start date
- Jan 1, 2025
- Status verified
- Jul 2024
- Primary completion
- Jan 1, 2026
- Completion
- Jan 1, 2026
Study Design
- Enrollment
- 112 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: BackfillParticipants will receive 200 mL of room temperature, sterile normal saline instilled retrograde into the bladder at the completion of the surgery prior to Foley catheter removal and the Foley subsequently removed intraoperatively.
- No Intervention: No bladder fillingParticipants will have the Foley catheter removed intraoperatively at completion of the procedure.
Primary Outcome Measure
Time to discharge [ Time Frame: Within 3 days following surgery ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Tennessee Health Science Center | Memphis | Tennessee | 38103 | John O Schorge, MD (PRINCIPAL_INVESTIGATOR) Emma Ryan, BS (SUB_INVESTIGATOR) Alex Samborski, MD (SUB_INVESTIGATOR) Riley Short, MD (SUB_INVESTIGATOR) Hunter R Harrison, MD (SUB_INVESTIGATOR) |
Find similar trials in Memphis, TN
By research site
Related Studies
- A Study to Determine the Preferred Dose of the Drug, Lisinopril, for Preventing Urinary Toxicity Following Radiotherapy for Prostate CancerEARLY_PHASE1 · Recruiting · University of Rochester · Rochester, New York
- PACU Discharge ReadinessNot Yet Recruiting · University of Illinois at Chicago · Chicago, Illinois